retatrutide type 1 diabetes RETATRUTIDE: A Medication for and Weight Loss Retatrutide for Weight Loss: TRIUMPH-1

Phase 3 TRIUMPH Programme Retatrutide has now entered the Phase 3 TRIUMPH clinical programme, one of the most expansive trial programmes currently underway in obesity and metabolic medicine

Explore the full story on GLP-1s and their role in reshaping the pharmaceutical landscape GLP-1s lead a historic shift as traditional drug costs outpace specialty drugs Traditional drugs, commonly used to treat everyday conditions such as high blood pressure, infections, and diabetes and have historically maintained stable costs due to generic drug expansion and industry-led cost-control methods

More than 5 million prescriptions for Ozempic, Mounjaro, Rybelsus, or Wegovy (all GLP-1s) were written for weight management in 2022, a 2,082% increase from 2019, Healthcare Brew previously reported

10.1038/srep08398 Sci

Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality